US$ 26.69
why did fda ban tirzepatide BANS Compounded Tirzepatide! Now What? Fifth Circuit probes FDA ban
Description
Sally Seymour of the FDA's Center for Drug Evaluation and Research

Shipping was quick, no problems

Tirzepatide (branded as Mounjaro) is FDA-approved and targets GLP-1 and GIP receptors
Tirzepatides dual agonist mechanism may accelerate progress, with some people reporting accelerated weight drops during the second month especially at doses above 10 mg (Journal of Clinical Medicine Research)

Nearly half (48.0%) had type 2 diabetes

Many of our members find that focusing on high-protein meals and staying hydrated significantly reduces the mild nausea that can sometimes accompany the start of treatment
